Navigation Links
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
Date:12/11/2007

NASDAQ: CRME TSX: COM

VANCOUVER and DEERFIELD, IL, Dec. 11 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that the FDA approve KYNAPID(TM), the intravenous formulation of vernakalant hydrochloride, an investigational new drug for rapid conversion of acute atrial fibrillation (AF).

At the panel review conducted today in Maryland, the members voted 6 to 2 in favour of recommending to the FDA that KYNAPID be approved for the rapid conversion of acute AF to sinus rhythm. If approved, KYNAPID will be the first new pharmacologic therapy for the conversion of AF in eight years.

"We are pleased with the committee's recommendation," said William E. Fitzsimmons, PharmD, Senior Vice President, Research & Development at Astellas. "We strongly believe in the therapeutic value of KYNAPID based on clinical trial data and are confident it will be an important therapy for people with atrial fibrillation."

"We welcome the committee's recommendation for approval, and look forward to the FDA completing their review and acting on the application early in the new year," stated Bob Rieder, Chief Executive Officer and Chairman of Cardiome. "People with atrial fibrillation suffer significant disease burden, and we are pleased to move an important step closer to providing doctors with an important tool for meeting this critical unmet medical need."

The Cardiovascular and Renal Drugs Advisory Committee is convened on request of the FDA, and reviews and evaluates available data concerning the safety and effectiveness of human drug products for use in the treatment of cardiovascular and renal disorders. Although the Committee provides recommendations to the Agency and suggests a course of action, final
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Nov. 30 SEIU Local 21... corporation Sodexo will hold a rally Tuesday, Dec...nance headquarters, 3800 Desire Parkway, New Orlea...bitrary disciplinary policies that target employee...y member. Sodexo employees who clean schools in th...
(Date:11/30/2009)... , Study Uses Tent To Simulate High Altitud...RNewswire-USNewswire/ -- Distance runners who live...n to improve their performance during races in are...ents, who suffer from fatigue, improve their exerc...titude simulator? ,, That is the question being...
(Date:11/30/2009)...EAPOLIS, Nov. 30 The Eject Helmet ...required equipment in the Top Fuel, Funny Car, Pro... National Hot Rod Association (NHRA) Full Throttle...agster and Top Alcohol Funny Car drivers in the NH...ly product that allows medical caregivers at race ...
(Date:11/30/2009)...er 30, 2009 ― Providing free medications to ...nts, lives at a relatively low cost for provincial...ers at St. Michael,s Hospital in Toronto. , "Ma...cribed medications because they simply don,t fill ...tudy,s lead author and a physician at St. Michael,...
(Date:11/30/2009)...ORK, Nov. 30 Reportlinker.com anno...le in its catalogue: ,, Key Players and Innova...ies in ingredients, pharma, food and drinks ,,...-and-Innovative-Start-Ups-in-Nutraceuticals-Emergi...s.html ,, Nutraceuticals are bioactive compoun...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
...e history has taught us that looks matter for ever...xt door, the economic crisis is forcing many consu...The results of consumer and plastic surgeon polls ...ick Place in Chicago October 31st through November...
...t. 28 "They said one pink,bus couldn,t change a c...r,Breast Health Education,s message on the side of...te area starting next week. The bus will promote t...cer Awareness Month, a time dedicated to,increasin...
...- Minimally-invasive surgery for lung cancer calle...atively new procedure performed almost exclusively... be presented this month at the annual CHEST meeti...n, cutting the major muscles overlying the chest. ...
...9th through November 2nd 2008, HARRISBURG, Pa., O...to attend the 2008 Annual Conference of The,Nation...PA). This year,s,theme, "Today,s Family and the Fa...e conference, which is open to the,public, will ta...
... ATI,s InLife™ and LifeView™ ...Home Telehealth for the Management of Heart Failur... Minneapolis (PRWEB) October 28, 2008 -- American ... InLife™ and LifeView™ Telehealth Syst...
...an Society of Plastic Surgeons Annual Meeting, Ch...riz. resident, Iraq War hero and motivational spea...roud recipient of the 2008 Patients of,Courage: Tr...e Patients of Courage: Triumph Over Adversity prog...
Other Medicine News:Health News:Consumers and plastic surgeons say economy is cutting into cosmetic procedures 2Health News:The Maurer Foundation Promotes Breast Health Message With Unique Traveling Pink Bus 2Health News:Highly-specialized, minimally-invasive surgery for lung cancer allows patient to go home sooner 2Health News:NAMI Pennsylvania Announces Program for Annual Statewide Conference 2Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 2Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 3Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 4Health News:Gilbert Resident, Iraq War Hero Wins Patient of Courage Award 2
(Date:11/30/2009)... , CHICAGO, Nov. 30 Minimall...ore costly open surgery, particularly in oncology,... a global market for image-guided navigation expec...embracing the advantages offered by minimally-inva...y times, greater patient comfort and faster patien...
(Date:11/30/2009)..., WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswire/...al Meeting of the Radiological Society of North ...nc. announced the enrollment of the first patient ...aluate the efficacy and safety of florbetaben (BAY...loid plaques in the brain, which are a pathologica...
(Date:11/30/2009)... , TEL AVIV, Israel, November 30 /PRNewsw...f the FOMRI-III(TM) dual channel microphone, the m...in functional magnetic resonance imaging,(fMRI) en...represents a major step forward for fiber,optic mi... quality ever, with,low-latency adaptive noise can...
Breaking Medicine Technology:Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 1Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 2Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 3Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 4Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 5Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 6Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 7GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 1GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 2GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 3Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 1Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 2
Attain LV Leads
Hancock® Standard Mitral Bioprosthesis
Vitality DS VR
...pact, portable ultrasound system which connects vi...mputer. The large display allows the entire scan t...he need for scrolling and changing back and forth ...the A-Scan 100 include built-in algorithms for dif...
Medicine Products: